Assignee
ASKLEPIOS BIOPHARMACEUTICAL INC
US7 patents
Top patents by PatentIndex Score
US9506052B2Nov 29, 2016
Modified factor VIII and factor IX genes
ASKLEPIOS BIOPHARMACEUTICAL INC9 citations82
US11268089B2Mar 8, 2022
Method for the construction of specific promoters
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations61
US11414678B2Aug 16, 2022
Modified soluble VEGF receptor-1 genes and vectors for gene therapy
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations60
US12036287B2Jul 16, 2024
Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations51
US11235070B2Feb 1, 2022
Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations51
US12241115B2Mar 4, 2025
Methods and compositions for enriching nucleic acids
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations37
US11492618B2Nov 8, 2022
Expression control using a regulatable intron
ASKLEPIOS BIOPHARMACEUTICAL INC0 citations34